| Document type: | Patente |
| Inventor(s): | Marcelo Lancellotti (FCF); Rafaella Fabiana Carneiro Pereira (IB); Daisy Machado (IB); Thaís Holtz Theizen (IB) |
| Applicant: | Universidade Estadual de Campinas (UNICAMP) |
| Deposit date: | November 2017, 17 |
| INPI register: | |
| IPC: | B82Y 5/00 A61P 31/04 A61K 9/16 B82Y 40/00 A61K 39/102 A61K 47/59 |
(EN) The present invention relates to a vaccine (OMV- Hae254) for Haemophilus aegyptius 254 (Hae254) comprising outer membrane vesicles (OMV) from the Haemophilus aegyptius 254 (Hae254) strain and mesoporous silica nanoparticles as an adjuvant.
| FAPESP's process: | 12/15046-3 - Study of the genome and metabolome of the Haemophilus influenzae strains causing the Brazilian purpuric fever |
| Grantee: | Marcelo Lancellotti |
| Principal Investigator: | Marcelo Lancellotti |
| Institution: | Universidade Estadual de Campinas (UNICAMP). Instituto de Biologia (IB) |
| Support Opportunities: | Regular Research Grants |
| FAPESP's process: | 11/14079-2 - Use of nanoparticles in vaccines against bacterial meningitis |
| Grantee: | Marcelo Lancellotti |
| Principal Investigator: | Marcelo Lancellotti |
| Institution: | Universidade Estadual de Campinas (UNICAMP). Instituto de Biologia (IB) |
| Support Opportunities: | Regular Research Grants |